Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
Intrauterine Drug Delivery Systems01:21

Intrauterine Drug Delivery Systems

Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimization of <i>Clausena anisata</i> leaf extract lozenges as smoking cessation aid: Quality by Design approach, trial-scale production at manufacturing site, and stability evaluation.

Drug development and industrial pharmacy·2026
Same author

Fabrication and evaluation of felodipine push-pull osmotic pump capsule.

Pharmaceutical development and technology·2025
Same author

Cluster analysis of fingerroot cultivated in different regions across Thailand and implementation of Quality by Design approach for R&D of fingerroot extract tablet.

Food research international (Ottawa, Ont.)·2025
Same author

Fabrication of Orally Fast-Disintegrating Wafer Tablets Containing Cannabis Extract Using Freeze-Drying Method.

Medical cannabis and cannabinoids·2024
Same author

Lipid nanoparticles for local delivery of mRNA to the respiratory tract: Effect of PEG-lipid content and administration route.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2024
Same author

Destabilization of Indomethacin-Paracetamol Co-Amorphous Systems by Mechanical Stress.

Pharmaceutics·2024

Related Experiment Video

Updated: Jul 6, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

Miscibility and interactions between 17beta-estradiol and Eudragit RS in solid dispersion.

Chutima Wiranidchapong1, Ian G Tucker, Thomas Rades

  • 1Department of Industrial Pharmacy, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok 10330, Thailand.

Journal of Pharmaceutical Sciences
|March 21, 2008
PubMed
Summary
This summary is machine-generated.

This study investigated the miscibility of 17beta-estradiol and Eudragit RS in solid dispersions. Findings indicate a significant interaction between these components, influencing their thermal properties and suggesting potential for improved drug delivery systems.

More Related Videos

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Related Experiment Videos

Last Updated: Jul 6, 2026

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs
08:18

Self-Nanoemulsification of Healthy Oils to Enhance the Solubility of Lipophilic Drugs

Published on: July 27, 2022

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles
07:32

Preparation and Characterization of Individual and Multi-drug Loaded Physically Entrapped Polymeric Micelles

Published on: August 28, 2015

Area of Science:

  • Pharmaceutical Sciences
  • Materials Science
  • Physical Chemistry

Background:

  • Solid dispersions are crucial for enhancing the solubility and bioavailability of poorly soluble drugs.
  • Understanding drug-polymer interactions is key to designing effective pharmaceutical formulations.
  • 17beta-estradiol is a vital hormone with therapeutic applications, often requiring formulation strategies for optimal delivery.

Purpose of the Study:

  • To determine the miscibility of 17beta-estradiol and Eudragit RS in solid dispersions.
  • To investigate the interactions between 17beta-estradiol and Eudragit RS using thermal analysis.
  • To characterize the physical state and interactions within the solid dispersion system.

Main Methods:

  • Modulated Temperature Differential Scanning Calorimetry (MTDSC) was employed to analyze solid dispersions.
  • Two distinct heating programs were utilized to assess melting point depression and glass transition temperature variations.
  • Fourier Transform Infrared (FTIR) spectroscopy was used to confirm intermolecular interactions.

Main Results:

  • MTDSC revealed a depression in the melting point of 17beta-estradiol within Eudragit RS solid dispersions, explained by the Nishi-Wang equation.
  • Variations in the glass transition temperature (Tg) of amorphous 17beta-estradiol were observed and modeled using the Kwei equation.
  • Analysis indicated a significant interaction between 17beta-estradiol and Eudragit RS, attributed to inter-associated hydrogen bonding.

Conclusions:

  • 17beta-estradiol and Eudragit RS exhibit miscibility in solid dispersions, evidenced by thermal behavior and interaction analysis.
  • The observed interactions, particularly hydrogen bonding, are critical factors influencing the physical properties of the solid dispersion.
  • These findings support the potential of Eudragit RS as a carrier for 17beta-estradiol in solid dispersion formulations.